John David Hansen - PRESIDENT AND CEO, Mabvax Therapeutics Holdings, Inc

As of October 4, 2017


John David Hansen Net Worth

  • Net worth is estimated to be at least $851.26K
  • Owns at least 70,601 units of Mabvax Therapeutics Holdings, Inc stock
  • Sold an estimated value of $34.36K in the last 7 months at Mabvax Therapeutics Holdings, Inc

John David Hansen Trading

  • Largest purchase of shares was 9,128 units , worth over $7.5K on August 2, 2017
  • Largest sale of shares was 10,216 units , worth over $20.43K on April 14, 2017
  • In total has made about 8 transactions over 7 months
  • Usually trades in April, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

John David Hansen Mailing Address

  • Mailing address is Mabvax Therapeutics Holdings, Inc. 11588 Sorrento Valley Road, Suite 20 San Diego CA 92121 CA

Mabvax Therapeutics Holdings, Inc Insider Trading

  • The most recent transaction was 35,442 units sold on January 24, 2018 by Jeffrey Eisenberg worth over $30.29K
  • In the last 3 years, insiders at Mabvax Therapeutics Holdings, Inc sold an estimated value of $841.22K and bought an estimated value of $39.55K
  • The most active traders are J. David Hansen, PRESIDENT AND CEO,  Gregory P Hanson, CHIEF FINANCIAL OFFICER,  and Paul W Maffuid, EXEC. VP
  • Insider trading is most common in April, with the busiest year in 2017

MABVAX THERAPEUTICS HOLDINGS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1